Trials / Conditions / Treatment-resistant Schizophrenia

Treatment-resistant Schizophrenia

30 registered clinical trials studyying Treatment-resistant Schizophrenia — 11 currently recruiting.

Status	Trial	Sponsor	Phase
Suspended	Low-Intensity Focused Ultrasound Neuromodulation of the Mediodorsal Thalamus for Treatment-Resistant Schizophr NCT05259306	NYU Langone Health	N/A
Not Yet Recruiting	Effectiveness of Exercise Alone and tDCS+Exercise on Cognitive Function Improvement in Patients With Treatment NCT07404319	Kit Wa Chan	N/A
Recruiting	Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment- NCT07184619	Newron Pharmaceuticals SPA	Phase 3
Recruiting	Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR. NCT07047651	Dr. Stavroula Rakitzi	Phase 4
Recruiting	Magnetic Seizure Therapy for Schizophrenia - Trial NCT06672588	Centre for Addiction and Mental Health	N/A
Recruiting	Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial NCT06456983	Central Institute of Mental Health, Mannheim	N/A
Recruiting	Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in Treatment-Resistant Schizophrenia NCT06749444	Jimmi Nielsen	N/A
Recruiting	Reduction of Auditory-Verbal Hallucinations in Schizophrenia Through Cortical Neuromodulation NCT06361160	Centre Hospitalier St Anne	N/A
Unknown	The Characteristics of Treatment Resistant Schizophrenia From the Illness Onset NCT06128408	Peking University	—
Unknown	Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Ana NCT06060886	Consorcio Centro de Investigación Biomédica en Red (CIBER)	Phase 4
Active Not Recruiting	Deep Brain Stimulation Recovery in Treatment-Resistant Schizophrenia NCT05337904	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	N/A
Completed	Dextromethorphan as an Augmentation Agent in Treatment-resistant Schizophrenia NCT05944510	All India Institute of Medical Sciences, Bhubaneswar	Phase 4
Terminated	An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine NCT05741502	Ohio State University	Phase 4
Recruiting	Effect of Atenolol Versus Ivabradine on HRV in TRS Patients on Clozapine With Tachycardia: A Randomised Contro NCT06505668	All India Institute of Medical Sciences, Bhubaneswar	N/A
Recruiting	Deep Brain Stimulation in Treatment Resistant Schizophrenia NCT02361554	Johns Hopkins University	N/A
Unknown	The Role of Glutamatergic Function in the Pathophysiology of Treatment-resistant Schizophrenia NCT06270108	King's College London	EARLY_Phase 1
Unknown	Hippocampus DBS in Treatment-resistant Schizophrenia NCT05694000	Shanghai Mental Health Center	N/A
Recruiting	Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations NCT05299749	Boston VA Research Institute, Inc.	N/A
Unknown	SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia NCT04528095	Shanghai Mental Health Center	Phase 3
Recruiting	Dundrum Forensic Redevelopment Evaluation Study: D-FOREST Study. NCT05074732	Health Service Executive, Ireland	—
Completed	Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019) NCT03983018	Region Örebro County	Phase 2
Unknown	Comparaison of Avatar Therapy to Cognitive Behavioral Therapy in Schizophrenia With Treatment Refractory Hallu NCT04054778	Ciusss de L'Est de l'Île de Montréal	N/A
Terminated	Telmisartan Pilot Study on Treatment Resistant Schizophrenia NCT03868839	Xiaoduo Fan	Phase 2
Completed	Comparison of Maintenance ECT Versus Clozapine in Treatment-resistant Schizophrenia NCT03807882	All India Institute of Medical Sciences, Bhubaneswar	Phase 4
Completed	Neural Biomarkers of Clozapine Response NCT03076346	University of Pittsburgh	—
Terminated	Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia NCT03230864	H. Lundbeck A/S	Phase 3
Completed	Avatar Therapy in Comparison to Cognitive Behavioral Therapy for Treatment-resistant Schizophrenia NCT03585127	Ciusss de L'Est de l'Île de Montréal	N/A
Completed	Virtual Reality Therapy for Treatment-resistant Auditory Hallucinations in Schizophrenia NCT03148639	Ciusss de L'Est de l'Île de Montréal	N/A
Completed	Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care NCT01431326	Daniel Benjamin	—
Completed	Amisulpride Augmentation Therapy for Clozapine-resistant Schizophrenic Patients NCT01105481	National Health Research Institutes, Taiwan	Phase 4